The Government's Rush To Judgment On Bernard Fisher's Work, Reputation

The Government's Rush To Judgment On Bernard Fisher's Work, Reputation The Scientist, Vol:9, #23, pg.12 , November 27, 1995. Author: Eugene Garfield                       Most readers of The Scientist probably are familiar with the case of Bernard Fisher, the University of Pittsburgh professor who had directed the National Surgical Adjuvant Breast and Bowel Project (NSABP) for more than two decades. Over that time, the 100 or so papers

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

But journalist John Crewdson of the Chicago Tribune reported on an Achilles' heel in NSABP. In this massive, multi-institutional, multinational, multimillion-dollar study funded by the National Cancer Institute (NCI), Crewdson wrote in 1994, a Canadian member of the project had enrolled some 100 ineligible patients (J. Crewdson, Chicago Tribune, March 13, 1994, page 1). Although a reanalysis concluded that these records did not affect the project's significance or conclusions, Fisher was removed by NCI as the NSABP director.

According to a recent report by Dan Greenberg in Science and Government Report (25:1-3, Nov. 1, 1995), the government has added insult to injury in the Fisher case. The National Library of Medicine (NLM) has placed "scientific misconduct" tags on the NSABP papers-some of which do not include the Canadian data-apparently under pressure from NCI. Donald Lindberg, NLM's director, acknowledges this as an extraordinary action, saying he knows of no other case ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo